These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery]. Yu Q; Xiong X; Sun Y Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):1-19. PubMed ID: 32621419 [TBL] [Abstract][Full Text] [Related]
23. The cullin protein family. Sarikas A; Hartmann T; Pan ZQ Genome Biol; 2011; 12(4):220. PubMed ID: 21554755 [TBL] [Abstract][Full Text] [Related]
24. Nonproteolytic K29-Linked Ubiquitination of the PB2 Replication Protein of Influenza A Viruses by Proviral Cullin 4-Based E3 Ligases. Karim M; Biquand E; Declercq M; Jacob Y; van der Werf S; Demeret C mBio; 2020 Apr; 11(2):. PubMed ID: 32265326 [TBL] [Abstract][Full Text] [Related]
25. Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1. Lu Y; Everett RD J Virol; 2015 Mar; 89(6):3062-75. PubMed ID: 25552717 [TBL] [Abstract][Full Text] [Related]
26. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription. Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312 [TBL] [Abstract][Full Text] [Related]
27. Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells. Luo Z; Pan Y; Jeong LS; Liu J; Jia L Autophagy; 2012 Nov; 8(11):1677-9. PubMed ID: 22874562 [TBL] [Abstract][Full Text] [Related]
28. Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds. Wu K; DeVita RJ; Pan ZQ J Biol Chem; 2024 Mar; 300(3):105752. PubMed ID: 38354780 [TBL] [Abstract][Full Text] [Related]
29. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells. Lan H; Tang Z; Jin H; Sun Y Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292 [TBL] [Abstract][Full Text] [Related]
30. Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8-activating enzyme by MLN4924. Liao H; Liu XJ; Blank JL; Bouck DC; Bernard H; Garcia K; Lightcap ES Mol Cell Proteomics; 2011 Nov; 10(11):M111.009183. PubMed ID: 21873567 [TBL] [Abstract][Full Text] [Related]
31. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system. Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561 [TBL] [Abstract][Full Text] [Related]
32. Ubiquitin E3 ligase CRL4(CDT2/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer. Pan WW; Zhou JJ; Yu C; Xu Y; Guo LJ; Zhang HY; Zhou D; Song FZ; Fan HY J Biol Chem; 2013 Oct; 288(41):29680-91. PubMed ID: 23995842 [TBL] [Abstract][Full Text] [Related]
33. Protein S-Nitrosylation of Human Cytomegalovirus pp71 Inhibits Its Ability To Limit STING Antiviral Responses. Nukui M; Roche KL; Jia J; Fox PL; Murphy EA J Virol; 2020 Aug; 94(17):. PubMed ID: 32581105 [TBL] [Abstract][Full Text] [Related]
35. Cullin 3-Based Ubiquitin Ligases as Master Regulators of Mammalian Cell Differentiation. Dubiel W; Dubiel D; Wolf DA; Naumann M Trends Biochem Sci; 2018 Feb; 43(2):95-107. PubMed ID: 29249570 [TBL] [Abstract][Full Text] [Related]
36. Rotavirus NSP1 Requires Casein Kinase II-Mediated Phosphorylation for Hijacking of Cullin-RING Ligases. Davis KA; Morelli M; Patton JT mBio; 2017 Aug; 8(4):. PubMed ID: 28851847 [TBL] [Abstract][Full Text] [Related]
37. Cullin E3 ligases and their rewiring by viral factors. Mahon C; Krogan NJ; Craik CS; Pick E Biomolecules; 2014 Oct; 4(4):897-930. PubMed ID: 25314029 [TBL] [Abstract][Full Text] [Related]
38. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease. Hussein ITM; Brooks J; Bowlin TL Antiviral Res; 2020 Apr; 176():104710. PubMed ID: 31940473 [TBL] [Abstract][Full Text] [Related]
39. Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives. Mercorelli B; Lembo D; Palù G; Loregian A Pharmacol Ther; 2011 Sep; 131(3):309-29. PubMed ID: 21570424 [TBL] [Abstract][Full Text] [Related]
40. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy. Zhao Y; Morgan MA; Sun Y Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]